HughesR.D., WilliamsR.. Clinical experience with charcoal and resin haemoperfusion.Semin Liver Dis1986; 6: 164–73.
2.
HughesR.D., WilliamsR.. Use of sorbent columns and haemofiltration in fulminant hepatic failure.Blood Purif1993; 11: 163–9.
3.
O'GradyJ.G., GimsonA.E.S., O'BrienC.J., PucknellA., HughesR.D., WilliamsR.. Controlled trials of charcoal haemoperfusion and prognostic factors in fulminant hepatic failure.Gastroenterology1988; 94: 1186–92.
4.
NybergS.L., ShatfordR.A., HuW-S, PayneW.D., CerraF.B.. Hepatocyte culture systems for artificial liver support: implications for critical care medicine (bioartificial liver support).Crit Care Med 192; 20: 1157–68.
5.
JaureguiH.O., GannK.L.. Mammalian hepatocytes as a foundation for treatment in human liver failure.J Cellular Biochem1991; 45: 359–65.
6.
GerlachJ.C., EnckeJ., HoleO., MullerC., CourtneyJ.M., NeuhausP.. Hepatocyte culture between three dimensionally arranged biomatrix-coated independent artificial capillary systems and sinusoidal endothelial cell co-culture compartments.Int J Artif Organs1994; 17: 301–6.
7.
SussmanN.L., ChongM.G., KoussayerT.. Reversal of fulminant hepatic failure using an extracorporeal liver assist device.Hepatology1992; 16: 60–5.
8.
RozgaJ., WilliamsF., RoM-S. Develpment of a bioartificial liver: properties and function of a hollow-fibre module inoculated with liver cells.Hepatology1993; 17: 258–65.
RozgaJ., PodestaL., LePageE.. A bioartificial liver to treat severe acute liver failure.Ann Surg1994; 5: 538–46.
11.
EllisA.J., WendonJ., HughesR.. A controlled trial of the Hepatix extracorporeal liver assist device (ELAD) in acute liver failure.Hepatology1994; 20: 140A.
12.
O'GradyJ.G., AlexanderG.L., HayllarK.M., WilliamsR.. Early indicators of prognosis in fulminant hepatic failure.Gastroenterology1989; 97: 439–45.
13.
AshS.R., BlakeD.E., CarrD.J., CarterC., HowardT.. Makowka L. Clinical effects of a sorbent suspension dialysis system in treatment of hepatic coma (the BioLogic-DT).Int J Artif Organs1992; 15: 151–61.
14.
HughesR.D., PucknellA., RoutleyD., LangleyP.G., WendonJ.A., WilliamsR.. Evaluation of the BioLogic-DT sorbent-suspension dialyser in patients with fulminant hepatic failure.Int J Artif Organ1994; 17: 657–62.
15.
OzawaK., AoyamaH., YasudaK.. Metabolic abnormalities associated with postoperative organ failure. A redox theory.Arch Surg1983; 118: 1245–51.
16.
SwainS., ButterworthR.F., BleiA.T.. Ammonia and related amino acids in the pathogenesis of brain edema in acute ischemic liver failure in rats.Hepatology1992; 15: 449–53.
17.
HilgierW., OlsonJ.E.. Brain ion and amino acid contents during edema development in hepatic encephalopathy.J Neurochem1994; 62: 197–204.
18.
HughesR.D., CochraneA.M.G., ThomsonA.D., Murray-LyonI.M., WilliamsR.. The cytotoxicity of plasma from patients with acute hepatic failure to isolated rabbit hepatocytes.Br J Exper Path1976; 57: 348–53.
